If you invested in American Healthcare REIT Inc. (NYSE: AHR), it’s essential to be aware of recent developments that may affect your investment. Below, Soreide Law Group provides a summary of the investment, potential concerns for investors, and how a securities attorney can assist you in recovering losses. American Healthcare REIT, a healthcare-focused real estate investment trust, has recently raised red flags due to liquidity concerns, declining asset values, and drops in share value. If you invested in this REIT, understanding the risks and seeking legal advice could be crucial to protecting your investment.
American Healthcare REIT Inc. (NYSE: AHR) is a real estate investment trust (REIT) specializing in healthcare-related properties. It was formed in 2021 through the merger of Griffin-American Healthcare REIT III, Griffin-American Healthcare REIT IV, and American Healthcare Investors. The REIT's portfolio includes healthcare properties such as medical office buildings, senior housing, hospitals, and skilled nursing facilities. AHR officially entered the public market with an IPO in February 2024, where it sold 64 million shares at $12 each.
Investors in American Healthcare REIT face concerns due to recent developments. The end of the lock-up period for legacy shareholders led to a drop in share value. Additionally, the REIT has faced challenges, such as a reported tender offer priced well below its NAV, a suspension of its repurchase plan, and reduced distributions. These issues indicate potential liquidity problems and declining asset values, raising red flags about the security of investors' capital.
Investments in non-traded REITs, like American Healthcare REIT, carry substantial risks. These include the inherent complexity and lack of liquidity, which can make it challenging for investors to sell their shares or recoup their original investment. Furthermore, the high sales commissions associated with REITs may incentivize brokers to make unsuitable recommendations, prioritizing their commissions over the investor’s best interests. This could lead to potential sales practice violations, such as misrepresentations, omissions, or breaches of fiduciary duty. Therefore, investors might pursue legal recourse through FINRA arbitration to recover their losses.
Did you suffer financially on your REIT investments? If so, touch base with Soreide Law Group online or at (888) 760-6552 and talk with a securities lawyer concerning a potential recovery of your investment losses. Soreide Law Group has recovered losses for investors throughout the United States, works on a contingency fee basis, and advances all costs.
Navigating the complexities of business and securities law requires precision, expertise, and a forward-thinking approach. At Soreide Law Group, we specialize in providing tailored legal solutions for companies, investors, and entrepreneurs across a wide range of services. Whether you are preparing financial disclosures or structuring innovative funding mechanisms, our team ensures compliance, clarity, and efficiency. […]
JOHN FRANCIS SCHLAGHECK (JOHN F SCHLAGHECK), according to FINRA’s BrokerCheck, available to the public on FINRA’s website, has been in the securities industry for 39 years and has been listed with 13 firms. Schlagheck has 13 disclosures on his FINRA CRD report, with 10 of the disclosures “Customer Disputes.” The significance of JOHN F SCHLAGHECK’s […]
Soreide Law Group has been contacted by investors who claimed they had experienced losses due to the alleged purchase of GPB Automotive stock through JAMES MICHAEL ARMOUR (JAMES M ARMOUR), currently listed with AUSDAL FINANCIAL PARTNERS, INC. of Wayzata, Minnesota since 2011. In February of 2021, GPB Automotive Portfolio, LP, was found to be a […]
Phone:
Fax: 1-954-760-6553
Email: [email protected]